Response to Smith and Shaw "Response to "Safety of dermatologic medications in pregnancy and lactation: An update - Part 1: Pregnancy & Part 2: Lactation""

J Am Acad Dermatol. 2024 Aug;91(2):e35-e36. doi: 10.1016/j.jaad.2024.04.017. Epub 2024 Apr 12.
No abstract available

Keywords: dermatologic therapy; fetus; gestation; lactation; medication safety; nursing; parturition; pregnancy; rituximab.

Publication types

  • Letter

MeSH terms

  • Dermatologic Agents* / adverse effects
  • Dermatologic Agents* / therapeutic use
  • Female
  • Humans
  • Lactation* / drug effects
  • Pregnancy
  • Pregnancy Complications / drug therapy

Substances

  • Dermatologic Agents